Mystery Solved Project 2025
The European Charcot Foundation (ECF) and the Mystery Solved Project (MSP) are delighted to host a groundbreaking virtual conference, bringing together leading global experts in multiple sclerosis (MS), Epstein-Barr virus (EBV), and immunology. This multidisciplinary event represents a unique opportunity to explore the latest research, engage in the scientific discussion and gain deeper insights into the interplay between virology, immunology, and neurodegenerative diseases.
About the Epstein-Barr Virus
Emerging research highlights the Epstein-Barr virus (EBV) as a critical factor in the development of multiple sclerosis (MS). This revelation has catalyzed a robust wave of scientific inquiry into EBV virology, adaptive immune responses, and their synergy in triggering pathogenic processes. The complex nature of EBV's role in autoimmune diseases is now at the forefront of investigative efforts, opening new pathways for potential therapies and prevention strategies.
Why Attend?
This virtual conference is a unique platform designed to facilitate interdisciplinary collaboration and knowledge exchange. Attendees will engage with pioneering virologists and immunologists specializing in autoimmune disease mechanisms, including B-cell and NK cell functionality. Clinical and neuropathological experts in multiple sclerosis will also share their expertise, integrating diverse perspectives to further our understanding of these interconnected fields. The event promises to inspire innovative approaches and foster partnerships aimed at unraveling the mysteries of MS and EBV.
Programme
You can view the programme of the event here.
Register now
MDEON Visum Application Number: 25/V2/16316/010135.
